Robo recruitment of the Wave regulatory complex plays an essential and conserved role in midline repulsion.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
12 04 2021
Historique:
received: 29 10 2020
accepted: 06 04 2021
pubmed: 13 4 2021
medline: 27 10 2021
entrez: 12 4 2021
Statut: epublish

Résumé

The Roundabout (Robo) guidance receptor family induces axon repulsion in response to its ligand Slit by inducing local cytoskeletal changes; however, the link to the cytoskeleton and the nature of these cytoskeletal changes are poorly understood. Here, we show that the heteropentameric Scar/Wave Regulatory Complex (WRC), which drives Arp2/3-induced branched actin polymerization, is a direct effector of Robo signaling. Biochemical evidence shows that Slit triggers WRC recruitment to the Robo receptor's WRC-interacting receptor sequence (WIRS) motif. In The brain is the most complex organ in the body. It contains billions of nerve cells, also known as neurons, with trillions of precise and specific connections, but how do these neurons know where to go and which connections to make as the brain grows? Neurons contain a small set of proteins known as guidance receptors. These receptors respond to external signals that can be attractive or repulsive. They instruct neurons to turn towards, or away from, the source of a signal. During embryonic development, neurons use these signals as guideposts to find their way to their destination. One such guidance receptor-signal pair consists of a receptor called Roundabout, also known as Robo, and its cue, Slit. Robo, which is located on the neuron’s surface, responds to the presence of Slit in the environment, by initiating a set of signalling events that instruct neurons to turn away. Neurons make the turn by rearranging their internal scaffolding, a network of proteins called the actin cytoskeleton. How Robo triggers this rearrangement is unclear. One possibility relies on a group of proteins called the WAVE regulatory complex, or the WRC for short. Researchers have already linked the WRC to nerve cell guidance, showing that it can trigger the growth of new filaments in the actin cytoskeleton. Proteins can activate the WRC by binding to it using a set of amino acids called a WRC-interacting receptor sequence, or WIRS for short, which Robo has. Chaudhari et al. used fruit flies to find out how Robo and the WRC interact. The experiments revealed that when Slit binds to Robo on the outside of a nerve cell, the WRC binds to Robo via its WIRS sequence on the inside of the cell. This attracts proteins inside the cell involved in rearranging the actin cytoskeleton. Disrupting this interaction by mutating either WRC or WIRS leads to severe errors in pathfinding, because when the WRC cannot connect to Robo, neurons cannot find their way. Experiments in mouse and chicken embryos showed that vertebrates use the WIRS sequence too, indicating that evolution has conserved this method of passing signals from Robo to the cytoskeleton. The fact that Slit and Robo work in the same way across fruit flies and vertebrates has implications for future medical research. Further work could explain how the brain and nervous system develop, and what happens when development goes wrong, but Slit and Robo control more than just nerve cell pathfinding. Research has linked disruptions in both proteins to many types of cancer, so a better understanding of how Robo interacts with the WRC could lead to new developments in different fields.

Autres résumés

Type: plain-language-summary (eng)
The brain is the most complex organ in the body. It contains billions of nerve cells, also known as neurons, with trillions of precise and specific connections, but how do these neurons know where to go and which connections to make as the brain grows? Neurons contain a small set of proteins known as guidance receptors. These receptors respond to external signals that can be attractive or repulsive. They instruct neurons to turn towards, or away from, the source of a signal. During embryonic development, neurons use these signals as guideposts to find their way to their destination. One such guidance receptor-signal pair consists of a receptor called Roundabout, also known as Robo, and its cue, Slit. Robo, which is located on the neuron’s surface, responds to the presence of Slit in the environment, by initiating a set of signalling events that instruct neurons to turn away. Neurons make the turn by rearranging their internal scaffolding, a network of proteins called the actin cytoskeleton. How Robo triggers this rearrangement is unclear. One possibility relies on a group of proteins called the WAVE regulatory complex, or the WRC for short. Researchers have already linked the WRC to nerve cell guidance, showing that it can trigger the growth of new filaments in the actin cytoskeleton. Proteins can activate the WRC by binding to it using a set of amino acids called a WRC-interacting receptor sequence, or WIRS for short, which Robo has. Chaudhari et al. used fruit flies to find out how Robo and the WRC interact. The experiments revealed that when Slit binds to Robo on the outside of a nerve cell, the WRC binds to Robo via its WIRS sequence on the inside of the cell. This attracts proteins inside the cell involved in rearranging the actin cytoskeleton. Disrupting this interaction by mutating either WRC or WIRS leads to severe errors in pathfinding, because when the WRC cannot connect to Robo, neurons cannot find their way. Experiments in mouse and chicken embryos showed that vertebrates use the WIRS sequence too, indicating that evolution has conserved this method of passing signals from Robo to the cytoskeleton. The fact that Slit and Robo work in the same way across fruit flies and vertebrates has implications for future medical research. Further work could explain how the brain and nervous system develop, and what happens when development goes wrong, but Slit and Robo control more than just nerve cell pathfinding. Research has linked disruptions in both proteins to many types of cancer, so a better understanding of how Robo interacts with the WRC could lead to new developments in different fields.

Identifiants

pubmed: 33843588
doi: 10.7554/eLife.64474
pii: 64474
pmc: PMC8096436
doi:
pii:

Substances chimiques

Drosophila Proteins 0
Microfilament Proteins 0
Nerve Tissue Proteins 0
Receptors, Immunologic 0
SCAR protein, Drosophila 0
Wasf1 protein, mouse 0
Wiskott-Aldrich Syndrome Protein Family 0
sli protein, Drosophila 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : R35 NS097340
Pays : United States

Informations de copyright

© 2021, Chaudhari et al.

Déclaration de conflit d'intérêts

KC, MG, CC, AK, GB No competing interests declared

Références

Cell. 2001 Oct 19;107(2):209-21
pubmed: 11672528
Neurology. 2005 Apr 12;64(7):1196-203
pubmed: 15824346
Nat Commun. 2016 Mar 31;7:11082
pubmed: 27029596
Neuron. 2003 Sep 25;40(1):113-27
pubmed: 14527437
Cold Spring Harb Protoc. 2010 Oct 01;2010(10):pdb.prot5504
pubmed: 20889701
Science. 2001 Apr 27;292(5517):737-40
pubmed: 11326102
Cell Rep. 2015 Oct 13;13(2):290-301
pubmed: 26440891
J Cancer. 2019 Jun 2;10(12):2694-2705
pubmed: 31258778
J Cell Biol. 2002 Feb 18;156(4):689-701
pubmed: 11854309
Dev Cell. 2011 Jun 14;20(6):827-40
pubmed: 21664580
Biochem Biophys Res Commun. 1996 Feb 15;219(2):509-14
pubmed: 8605018
Cell. 2000 Dec 22;103(7):1033-45
pubmed: 11163180
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1098-103
pubmed: 15657136
Neuron. 2003 Jan 9;37(1):53-65
pubmed: 12526772
Nature. 2010 Nov 25;468(7323):533-8
pubmed: 21107423
Front Cell Neurosci. 2014 Mar 27;8:81
pubmed: 24733999
Elife. 2017 Sep 26;6:
pubmed: 28949297
Mol Cell Biol. 2009 Apr;29(7):1735-48
pubmed: 19158278
Cell. 2000 Dec 22;103(7):1019-32
pubmed: 11163179
Cell. 1999 Mar 19;96(6):795-806
pubmed: 10102268
Mol Biol Cell. 2011 Nov;22(21):4079-92
pubmed: 21900504
Curr Biol. 2010 Mar 23;20(6):567-72
pubmed: 20206526
J Morphol. 1951 Jan;88(1):49-92
pubmed: 24539719
Pathol Oncol Res. 2019 Oct;25(4):1285-1293
pubmed: 30610466
J Cell Biol. 2016 Apr 25;213(2):261-74
pubmed: 27091449
Cell. 1991 Feb 22;64(4):801-15
pubmed: 1997208
Genetics. 2008 Aug;179(4):1957-71
pubmed: 18689885
Cell. 2014 Jan 16;156(1-2):195-207
pubmed: 24439376
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8844-9
pubmed: 11438699
Circ Res. 2013 Feb 1;112(3):465-75
pubmed: 23255421
Cell. 2014 Jan 16;156(1-2):208-20
pubmed: 24439377
Nature. 2002 Aug 15;418(6899):790-3
pubmed: 12181570
Cell. 1992 Aug 7;70(3):401-10
pubmed: 1643658
Cell Adh Migr. 2011 Sep-Oct;5(5):402-8
pubmed: 21975549
Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1019-27
pubmed: 18270976
Neuron. 2003 Jun 19;38(6):887-98
pubmed: 12818175
Development. 2019 Feb 4;146(3):
pubmed: 30674481
Cell. 2000 Jun 23;101(7):703-15
pubmed: 10892742
G3 (Bethesda). 2015 Sep 10;5(11):2429-39
pubmed: 26362767
Curr Biol. 2005 Dec 20;15(24):2271-8
pubmed: 16360689
Cell. 2010 Feb 5;140(3):409-20
pubmed: 20144763
Cell. 1999 Mar 19;96(6):785-94
pubmed: 10102267
Elife. 2018 Mar 14;7:
pubmed: 29537369
Mol Biol Cell. 2016 Nov 1;27(21):3342-3356
pubmed: 27605705
PLoS Genet. 2015 Sep 03;11(9):e1005402
pubmed: 26335920
PLoS Genet. 2005 Oct;1(4):e50
pubmed: 16254601
Cell. 1998 Jan 23;92(2):205-15
pubmed: 9458045
Curr Biol. 2004 Aug 10;14(15):1319-29
pubmed: 15296748
Neuron. 2004 Apr 22;42(2):213-23
pubmed: 15091338
EMBO J. 2015 Aug 13;34(16):2147-61
pubmed: 26124312
PLoS Genet. 2012;8(11):e1003054
pubmed: 23209429
Nat Struct Mol Biol. 2009 May;16(5):561-3
pubmed: 19363480
Nat Cell Biol. 2005 Oct;7(10):977-84
pubmed: 16155589
Neuron. 2006 Nov 22;52(4):595-607
pubmed: 17114045
Sci Rep. 2019 Aug 19;9(1):12009
pubmed: 31427645
Dev Cell. 2014 Sep 8;30(5):569-84
pubmed: 25203209
Neuron. 1993 Mar;10(3):409-26
pubmed: 8461134
Dev Biol. 2004 Oct 15;274(2):260-70
pubmed: 15385157
Neurology. 2011 Jan 18;76(3):260-4
pubmed: 21242494
J Biol Chem. 2005 Aug 5;280(31):28653-62
pubmed: 15939738
Development. 2002 Nov;129(21):4941-51
pubmed: 12397103
Nat Med. 2015 May;21(5):483-91
pubmed: 25894826
Science. 2004 Jun 4;304(5676):1509-13
pubmed: 15105459
J Neurobiol. 2003 Oct;57(1):15-30
pubmed: 12973825
Mol Autism. 2011 Aug 22;2(1):14
pubmed: 21859478
Development. 2010 Jul;137(14):2417-26
pubmed: 20570941
Development. 2005 Apr;132(8):1983-94
pubmed: 15790972
Science. 2015 Nov 20;350(6263):961-5
pubmed: 26586761

Auteurs

Karina Chaudhari (K)

Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.

Madhavi Gorla (M)

Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.

Chao Chang (C)

Institut de recherches cliniques de Montréal (IRCM), Montréal, Canada.
Department of Anatomy and Cell Biology and Division of Experimental Medicine, McGill University, Montréal, Canada.

Artur Kania (A)

Institut de recherches cliniques de Montréal (IRCM), Montréal, Canada.
Department of Anatomy and Cell Biology and Division of Experimental Medicine, McGill University, Montréal, Canada.

Greg J Bashaw (GJ)

Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH